Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 24 | 2024 | 3812 | 1.410 |
Why?
|
RNA, Untranslated | 8 | 2024 | 459 | 0.870 |
Why?
|
Myocardial Reperfusion Injury | 5 | 2024 | 481 | 0.860 |
Why?
|
Myocytes, Cardiac | 15 | 2024 | 1668 | 0.850 |
Why?
|
Metabolic Diseases | 3 | 2023 | 681 | 0.740 |
Why?
|
Nucleic Acids | 1 | 2023 | 188 | 0.700 |
Why?
|
RNA, Transfer | 1 | 2022 | 292 | 0.670 |
Why?
|
Octamer Transcription Factor-6 | 2 | 2017 | 3 | 0.620 |
Why?
|
Protein Kinases | 1 | 2023 | 1607 | 0.530 |
Why?
|
Sirtuin 1 | 1 | 2017 | 246 | 0.510 |
Why?
|
Muscular Atrophy | 4 | 2023 | 333 | 0.500 |
Why?
|
Cardiomegaly | 6 | 2023 | 591 | 0.490 |
Why?
|
Neural Tube Defects | 1 | 2017 | 255 | 0.480 |
Why?
|
Embryonic Stem Cells | 6 | 2020 | 1263 | 0.440 |
Why?
|
Cell Communication | 4 | 2023 | 1657 | 0.400 |
Why?
|
Exercise | 9 | 2024 | 5884 | 0.370 |
Why?
|
Aging | 5 | 2024 | 8705 | 0.330 |
Why?
|
Heart Failure | 8 | 2024 | 11674 | 0.310 |
Why?
|
Oxidative Stress | 3 | 2023 | 3110 | 0.300 |
Why?
|
Heart | 6 | 2024 | 4405 | 0.300 |
Why?
|
RNA | 6 | 2024 | 2723 | 0.300 |
Why?
|
Atrial Fibrillation | 2 | 2023 | 5127 | 0.280 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15498 | 0.260 |
Why?
|
Meningioma | 2 | 2024 | 1218 | 0.240 |
Why?
|
Myocardium | 5 | 2024 | 4725 | 0.210 |
Why?
|
Cardiovascular System | 2 | 2023 | 835 | 0.210 |
Why?
|
Autophagy | 2 | 2022 | 1326 | 0.210 |
Why?
|
Mitral Valve Prolapse | 1 | 2024 | 215 | 0.200 |
Why?
|
Environmental Exposure | 1 | 2017 | 4467 | 0.200 |
Why?
|
RNA, Nuclear | 1 | 2021 | 30 | 0.190 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8596 | 0.190 |
Why?
|
Mice | 24 | 2024 | 81509 | 0.180 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2024 | 455 | 0.180 |
Why?
|
Animals | 33 | 2024 | 168441 | 0.180 |
Why?
|
Heart Diseases | 3 | 2024 | 2785 | 0.180 |
Why?
|
Ventricular Remodeling | 3 | 2023 | 1266 | 0.170 |
Why?
|
Physical Exertion | 1 | 2022 | 667 | 0.160 |
Why?
|
Neural Stem Cells | 2 | 2017 | 888 | 0.160 |
Why?
|
Paracrine Communication | 1 | 2020 | 276 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2024 | 988 | 0.160 |
Why?
|
Mechanotransduction, Cellular | 1 | 2023 | 529 | 0.160 |
Why?
|
Chemokines | 1 | 2022 | 959 | 0.150 |
Why?
|
Cell Differentiation | 8 | 2022 | 11526 | 0.150 |
Why?
|
Pericytes | 1 | 2020 | 293 | 0.150 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2019 | 241 | 0.150 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2023 | 740 | 0.150 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2020 | 353 | 0.150 |
Why?
|
Adenosine | 2 | 2022 | 808 | 0.140 |
Why?
|
Lung Injury | 1 | 2022 | 422 | 0.140 |
Why?
|
Meningeal Neoplasms | 2 | 2024 | 1248 | 0.140 |
Why?
|
Neural Tube | 1 | 2017 | 48 | 0.140 |
Why?
|
RNA-Binding Proteins | 2 | 2024 | 1897 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 808 | 0.140 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2022 | 740 | 0.140 |
Why?
|
Endopeptidases | 1 | 2020 | 773 | 0.140 |
Why?
|
Signal Transduction | 9 | 2024 | 23441 | 0.140 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2023 | 555 | 0.140 |
Why?
|
Oncolytic Viruses | 1 | 2020 | 344 | 0.140 |
Why?
|
Islets of Langerhans | 1 | 2023 | 1346 | 0.140 |
Why?
|
Cell Proliferation | 5 | 2024 | 10441 | 0.130 |
Why?
|
Reperfusion Injury | 1 | 2023 | 1023 | 0.130 |
Why?
|
RNA, Messenger | 5 | 2022 | 12796 | 0.130 |
Why?
|
DNA Damage | 2 | 2017 | 2446 | 0.130 |
Why?
|
Humans | 44 | 2024 | 761423 | 0.130 |
Why?
|
Exosomes | 1 | 2020 | 424 | 0.130 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.130 |
Why?
|
Cells, Cultured | 6 | 2024 | 18964 | 0.120 |
Why?
|
Base Sequence | 3 | 2022 | 12450 | 0.120 |
Why?
|
Erythrocytes | 2 | 2021 | 2419 | 0.120 |
Why?
|
Neural Crest | 1 | 2017 | 279 | 0.120 |
Why?
|
Pluripotent Stem Cells | 1 | 2022 | 799 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3874 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2416 | 0.120 |
Why?
|
Extracellular Matrix | 1 | 2022 | 1725 | 0.120 |
Why?
|
Immune System | 1 | 2020 | 795 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2022 | 1903 | 0.120 |
Why?
|
Rats | 7 | 2024 | 23742 | 0.110 |
Why?
|
Activin Receptors, Type II | 1 | 2014 | 123 | 0.110 |
Why?
|
Rad51 Recombinase | 1 | 2014 | 189 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2020 | 0.110 |
Why?
|
Neoplasms | 2 | 2022 | 22164 | 0.110 |
Why?
|
Immunity | 1 | 2020 | 997 | 0.110 |
Why?
|
Defibrillators, Implantable | 1 | 2023 | 1490 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2023 | 1642 | 0.100 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3798 | 0.100 |
Why?
|
Ubiquitination | 1 | 2017 | 1006 | 0.100 |
Why?
|
Glucose | 1 | 2024 | 4347 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11458 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2009 | 0.090 |
Why?
|
Quality of Life | 2 | 2023 | 13361 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2020 | 1220 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1955 | 0.090 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18247 | 0.090 |
Why?
|
Apoptosis | 5 | 2024 | 9488 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2449 | 0.090 |
Why?
|
Glycolysis | 2 | 2024 | 836 | 0.090 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22163 | 0.080 |
Why?
|
Air Pollution | 1 | 2022 | 2348 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8545 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3879 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4766 | 0.070 |
Why?
|
Doxorubicin | 2 | 2024 | 2224 | 0.070 |
Why?
|
Glioblastoma | 1 | 2020 | 3482 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2045 | 0.060 |
Why?
|
Gene Expression Regulation | 6 | 2020 | 11902 | 0.060 |
Why?
|
Endothelial Cells | 3 | 2023 | 3541 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3407 | 0.060 |
Why?
|
Utrophin | 1 | 2023 | 15 | 0.060 |
Why?
|
Lung | 1 | 2023 | 9995 | 0.060 |
Why?
|
RNA Interference | 3 | 2018 | 2831 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7856 | 0.060 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2024 | 411 | 0.050 |
Why?
|
Ribose | 1 | 2022 | 63 | 0.050 |
Why?
|
Omentum | 1 | 2023 | 168 | 0.050 |
Why?
|
Carbocyanines | 1 | 2022 | 175 | 0.050 |
Why?
|
Remote Sensing Technology | 1 | 2023 | 92 | 0.050 |
Why?
|
Cathepsins | 1 | 2022 | 241 | 0.050 |
Why?
|
Macrolides | 1 | 2022 | 205 | 0.050 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2022 | 329 | 0.050 |
Why?
|
Rats, Transgenic | 1 | 2020 | 69 | 0.050 |
Why?
|
Physical Conditioning, Animal | 1 | 2024 | 365 | 0.040 |
Why?
|
Primates | 1 | 2023 | 524 | 0.040 |
Why?
|
Cathelicidins | 1 | 2020 | 80 | 0.040 |
Why?
|
Homeostasis | 2 | 2023 | 3321 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 184 | 0.040 |
Why?
|
Methyltransferases | 1 | 2022 | 377 | 0.040 |
Why?
|
Angiotensin II | 1 | 2022 | 848 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2871 | 0.040 |
Why?
|
Motion | 1 | 2023 | 779 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3839 | 0.040 |
Why?
|
Forecasting | 2 | 2018 | 2928 | 0.040 |
Why?
|
Arginine | 1 | 2022 | 933 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2023 | 1170 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9535 | 0.040 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2018 | 71 | 0.040 |
Why?
|
Neurons | 1 | 2017 | 9462 | 0.040 |
Why?
|
Physical Fitness | 1 | 2022 | 739 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 865 | 0.040 |
Why?
|
Mice, Nude | 1 | 2024 | 3614 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13637 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1588 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2023 | 2230 | 0.030 |
Why?
|
Heart Atria | 1 | 2022 | 1347 | 0.030 |
Why?
|
Actins | 1 | 2024 | 2050 | 0.030 |
Why?
|
RNA Stability | 1 | 2018 | 329 | 0.030 |
Why?
|
Culture Media, Serum-Free | 1 | 2016 | 148 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2020 | 696 | 0.030 |
Why?
|
China | 1 | 2022 | 2366 | 0.030 |
Why?
|
Body Fluids | 1 | 2018 | 320 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2024 | 1974 | 0.030 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 737 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1960 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2022 | 14409 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2022 | 928 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13502 | 0.030 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2018 | 416 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2023 | 1685 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1330 | 0.030 |
Why?
|
Oncolytic Virotherapy | 1 | 2020 | 516 | 0.030 |
Why?
|
DNA Breaks | 1 | 2014 | 47 | 0.030 |
Why?
|
United States | 1 | 2023 | 72339 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2020 | 1115 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1877 | 0.030 |
Why?
|
Regeneration | 1 | 2023 | 1511 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2023 | 4808 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2018 | 902 | 0.030 |
Why?
|
Cell Survival | 1 | 2024 | 5790 | 0.030 |
Why?
|
Cell Membrane | 1 | 2023 | 3687 | 0.030 |
Why?
|
Aortic Valve | 1 | 2024 | 1961 | 0.030 |
Why?
|
Cell Line | 2 | 2017 | 15605 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2824 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2048 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2022 | 2161 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1793 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 736 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2018 | 1093 | 0.030 |
Why?
|
Male | 7 | 2024 | 360736 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 519 | 0.030 |
Why?
|
Blood Platelets | 1 | 2023 | 2481 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9606 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9469 | 0.020 |
Why?
|
Leukocytes | 1 | 2020 | 2028 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4228 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4354 | 0.020 |
Why?
|
Stem Cells | 1 | 2023 | 3522 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 3007 | 0.020 |
Why?
|
Particulate Matter | 1 | 2022 | 2595 | 0.020 |
Why?
|
Fibroblasts | 1 | 2020 | 4140 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3623 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 8179 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4430 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5789 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2555 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5203 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7049 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16979 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3612 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6055 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 3517 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5768 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3081 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7584 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7392 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7409 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12330 | 0.010 |
Why?
|
Female | 4 | 2024 | 392581 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3447 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8641 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22168 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8000 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39117 | 0.010 |
Why?
|
Proteins | 1 | 2016 | 6032 | 0.010 |
Why?
|
Aged | 2 | 2024 | 169235 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12938 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41446 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10762 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5840 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 220826 | 0.010 |
Why?
|
Adult | 2 | 2024 | 221148 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 58956 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36423 | 0.010 |
Why?
|
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_